5,999 Shares in CVS Health Corporation $CVS Bought by Efficient Advisors LLC

Efficient Advisors LLC purchased a new position in shares of CVS Health Corporation (NYSE:CVS) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 5,999 shares of the pharmacy operator’s stock, valued at approximately $414,000.

A number of other hedge funds also recently made changes to their positions in CVS. Avion Wealth increased its stake in CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 189 shares during the period. Harbor Asset Planning Inc. acquired a new stake in CVS Health during the second quarter valued at approximately $30,000. Bell Investment Advisors Inc grew its stake in shares of CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 248 shares during the period. Roxbury Financial LLC raised its holdings in shares of CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 202 shares in the last quarter. Finally, ORG Partners LLC lifted its position in shares of CVS Health by 418.9% during the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 377 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Buying and Selling

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the business’s stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.22% of the stock is currently owned by insiders.

CVS Health Trading Up 0.4%

Shares of NYSE CVS opened at $79.00 on Friday. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $85.15. The company has a 50-day moving average of $77.15 and a two-hundred day moving average of $69.45. The company has a market cap of $100.29 billion, a PE ratio of 207.90, a P/E/G ratio of 0.87 and a beta of 0.60. The company has a current ratio of 0.83, a quick ratio of 0.62 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. During the same quarter last year, the business posted $1.09 earnings per share. CVS Health’s revenue for the quarter was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.4%. CVS Health’s dividend payout ratio (DPR) is currently 700.00%.

Wall Street Analyst Weigh In

Several research analysts have issued reports on CVS shares. Cowen reiterated a “buy” rating on shares of CVS Health in a research note on Monday, August 4th. Leerink Partners increased their target price on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, October 16th. Cantor Fitzgerald boosted their price target on shares of CVS Health from $78.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, October 30th. UBS Group raised their price objective on shares of CVS Health from $79.00 to $96.00 and gave the stock a “buy” rating in a report on Friday, October 24th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of CVS Health in a report on Wednesday. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $89.45.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.